91 related articles for article (PubMed ID: 19545933)
1. CALHM1 variant is not associated with Alzheimer's disease among Asians.
Tan EK; Ho P; Cheng SY; Yih Y; Li HH; Fook-Chong S; Lee WL; Zhao Y
Neurobiol Aging; 2011 Mar; 32(3):546.e11-2. PubMed ID: 19545933
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
[TBL] [Abstract][Full Text] [Related]
3. Lack of implication for CALHM1 P86L common variation in Italian patients with early and late onset Alzheimer's disease.
Nacmias B; Tedde A; Bagnoli S; Lucenteforte E; Cellini E; Piaceri I; Guarnieri BM; Bessi V; Bracco L; Sorbi S
J Alzheimers Dis; 2010; 20(1):37-41. PubMed ID: 20164602
[TBL] [Abstract][Full Text] [Related]
4. No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population.
Fehér A; Juhász A; Rimanóczy A; Pákáski M; Kálmán J; Janka Z
Psychiatr Genet; 2011 Oct; 21(5):249-52. PubMed ID: 21378601
[TBL] [Abstract][Full Text] [Related]
5. A polymorphism in CALHM1 is associated with temporal lobe epilepsy.
Lv RJ; He JS; Fu YH; Shao XQ; Wu LW; Lu Q; Jin LR; Liu H
Epilepsy Behav; 2011 Apr; 20(4):681-5. PubMed ID: 21439911
[TBL] [Abstract][Full Text] [Related]
6. CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model.
Boada M; Antúnez C; López-Arrieta J; Galán JJ; Morón FJ; Hernández I; Marín J; Martínez-Lage P; Alegret M; Carrasco JM; Moreno C; Real LM; González-Pérez A; Tárraga L; Ruiz A
J Alzheimers Dis; 2010; 20(1):247-51. PubMed ID: 20164592
[TBL] [Abstract][Full Text] [Related]
7. No association between CALHM1 and risk for Alzheimer dementia in a Belgian population.
Sleegers K; Brouwers N; Bettens K; Engelborghs S; van Miegroet H; De Deyn PP; Van Broeckhoven C
Hum Mutat; 2009 Apr; 30(4):E570-4. PubMed ID: 19191332
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
[TBL] [Abstract][Full Text] [Related]
9. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
[TBL] [Abstract][Full Text] [Related]
10. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
[TBL] [Abstract][Full Text] [Related]
12. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
Tolppanen AM; Helisalmi S; Hiltunen M; Kolehmainen M; Schwab U; Pirttilä T; Pulkkinen L; Uusitupa M; Soininen H
Neurobiol Aging; 2011 Mar; 32(3):546.e7-9. PubMed ID: 19524323
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor gamma (PPAR-gamma2) Pro12Ala polymorphism is associated with higher risk for Alzheimer's disease in octogenarians.
Scacchi R; Pinto A; Gambina G; Rosano A; Corbo RM
Brain Res; 2007 Mar; 1139():1-5. PubMed ID: 17270153
[TBL] [Abstract][Full Text] [Related]
14. Genetic association of CTNNA3 with late-onset Alzheimer's disease in females.
Miyashita A; Arai H; Asada T; Imagawa M; Matsubara E; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Toyabe S; Akazawa K; Kanazawa I; Ihara Y; Kuwano R;
Hum Mol Genet; 2007 Dec; 16(23):2854-69. PubMed ID: 17761686
[TBL] [Abstract][Full Text] [Related]
15. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
Bian JT; Zhang JW; Zhang ZX; Zhao HL
Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
[TBL] [Abstract][Full Text] [Related]
17. [CALHM1, a novel gene to blame in Alzheimer disease].
Lambert JC; Campagne F; Marambaud P
Med Sci (Paris); 2008 Nov; 24(11):923-4. PubMed ID: 19038093
[No Abstract] [Full Text] [Related]
18. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
[TBL] [Abstract][Full Text] [Related]
19. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
[TBL] [Abstract][Full Text] [Related]
20. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease.
Tedde A; Bagnoli S; Piaceri I; Lucenteforte E; Bessi V; Bracco L; Mugelli A; Sorbi S; Nacmias B
Neurosci Lett; 2010 Jun; 477(3):121-3. PubMed ID: 20430066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
